Prostate Cancer

Prostate cancer treatment has undergone major changes over the course of the past few years and the pace of new research and development is expected to continue at a high level for the immediate future. This title provides a comprehensive review for practitioners on the status of prostate cancer treatment.

---

Emerging Cancer Therapeutics is a trinary, hard cover, periodical that is designed to provide an up-to-date evidence-based review of a dedicated emerging cancer therapy topic of interest to clinicians and scientists who are involved in the care of patients receiving cancer treatment. It will serve as both a reference and instructional tool for students, house staff, fellows, practising clinical oncologists, radiation oncologists, surgical oncologists, cancer biologists, and interdisciplinary colleagues throughout the oncology spectrum.

With contributions from experts across the United States and Canada, Prostate Cancer details the current management of prostate cancer and reviews new therapies in development for prostate cancer, with an emphasis on castration-resistant prostate cancer (CRPC). Coverage includes discussion of multiple new agents that have been shown to impact overall survival or improve skeletal-related events in metastatic CRPC as well as articles covering new data on screening and prevention, integration of surgery and radiation with newly emerging medical therapies, and coverage of the newest developments in immunotherapy. This book is a valuable tool for clinicians, nurses, researchers, medical students, residents, and fellows.



Included in Prostate Cancer:
Updates in Prostate Cancer Prevention
Prostate Cancer Screening, 2011
Current Surgical Approaches to Primary Prostate Cancer Treatment
Updates in Radiation Therapy for Prostate Cancer: Dose Matters

An Update on Androgen-Deprivation Therapy for Advanced Prostate Cancer
Novel Androgen Receptor Therapeutic Targets for Advanced Prostate Cancer
New Understanding of Metabolic Complications of Androgen-Deprivation Therapy
Current State of Docetaxel-Based Therapy in Castration-Resistant Prostate Cancer
Second-Line Chemotherapy for Castration-Resistant Prostate Cancer
Emerging Role of Immunotherapy in the Treatment of Prostate Cancer
Novel Bone-Targeted Therapy in Metastatic Prostate Cancer
Emerging Treatment Strategies for Metastatic Prostate Cancer: The Next Step Forward